Medicine and Dentistry
Tacrolimus
100%
Patient
100%
Graft Survival
33%
Therapeutic Procedure
33%
Combination Therapy
25%
Incidence
25%
Arm
25%
Follow up
16%
Immunosuppressive Treatment
16%
Adverse Event
16%
Cyclosporine
16%
Kidney Transplantation
16%
Graft Failure
16%
Hypertension
8%
Acute Graft Rejection
8%
Cardiovascular Risk
8%
Hyperlipidemia
8%
Intention-to-Treat Analysis
8%
Kidney Allograft
8%
Insulin Dependence
8%
Analysis
8%
Nursing and Health Professions
Tacrolimus
100%
Graft Survival
33%
Combination Therapy
25%
Incidence
25%
Adverse Event
16%
Follow up
16%
Graft Failure
16%
Kidney Transplantation
16%
Immunosuppressive Treatment
16%
Ciclosporin
16%
Hypertension
8%
Drug Therapy
8%
Cardiovascular Risk
8%
Treatment Failure
8%
Intention to Treat Analysis
8%
Acute Graft Rejection
8%
Hyperlipidemia
8%
Kidney Allograft
8%
Analysis
8%
Control
8%
Procedures
8%
Insulin Dependence
8%
Immunology and Microbiology
Tacrolimus
100%
Survival
33%
Incidence
25%
Arm
25%
Allotransplantation
16%
Ciclosporin
16%
Kidney Transplantation
16%
Acute Graft Rejection
8%
Immunosuppressive Therapy
8%
Reduction (Chemistry)
8%
Kidney
8%
Immunosuppression
8%
INIS
patients
50%
grafts
41%
therapy
33%
kidneys
25%
failures
25%
risks
16%
cyclosporine
16%
comparative evaluations
8%
control
8%
hypertension
8%
insulin
8%
reduction
8%
immunosuppression
8%
Biochemistry, Genetics and Molecular Biology
Survival
33%
Incidence
25%
Hyperlipidemia
8%
Reduction (Chemistry)
8%
Insulin Dependence
8%